Good News for Heart Patients: India's First Digital Therapeutics Study Shows Positive Results for ACS Treatment

India's first evidence-based digital therapeutics tool  "Lyfe" was created by Lupin Digital Health. This platform seeks to lower the risk of a heart attack and enhance cardiac patients' quality of life. Recent research by LDH examined Lyfe's efficacy in treating heart patients over the course of a year.

The purpose of the research was to assess the impact of LDH's digital therapeutics platform on heart patients' vital sign monitoring, medication adherence, cardiovascular events, rehospitalization and lifestyle changes. Patients in the program showed substantial improvement over the course of the 90-day interim analysis, and 90% of them continued to follow the prescribed medication, diet and exercise schedule. Additionally, no rehospitalizations occurred in the first 30 days of treatment and 83.3% of patients kept their vital signs within the acceptable range.

The study's conclusions were showcased in Chennai at the India Live 2023 symposium. The study's findings suggest that, with the help of technology, digital therapeutics initiatives will play a significant part in patient care throughout the cardiology continuum. With the potential of digital health to enhance patients' heart health, these findings indicate a bright future for remote patient care in cardiology.

Cardiologist Dr. Abhijeet P from Pune, India, expressed his satisfaction over the successful outcomes of the research. He expressed, "We are revolutionizing the way we provide healthcare to our patients by utilizing evidence-based tools like digital therapeutics". While this is a great start, we want to establish digital therapeutics in cardiology and unleash its potential by conducting extensive clinical studies and encouraging collaboration among all healthcare stakeholders.

The CEO of Lupin Digital Health, Sidharth Srinivasan, also stated how happy he was with the study's fruitful findings. The study's findings, he continued, "demonstrate the efficacy of our evidence-based, all-inclusive heart care program in assuring high patient adherence and low rehospitalization rates. We are committed to maximizing the patient experience through bettering the doctor-patient relationship, monitoring patient health data constantly, raising patient awareness, and enhancing therapy adherence, all of which will improve outcomes.

Overall, the study's encouraging findings suggest that digital therapeutics initiatives could completely alter how patients receive care in the field of cardiology. Digital therapeutics are one example of an evidence-based technology that healthcare providers can use to better patient outcomes.

Disclaimer : The information provided in this article is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosis or treatment. If you have any concerns about your health or are experiencing symptoms, it is important to consult with a healthcare professional. They will be able to assess your specific situation and provide you with personalised advice and treatment based on your symptoms, body type, allergies (if any), existing medical conditions etc. It is always a good idea to consult with a healthcare professional before making any decisions about your health.